Endurance Wealth Management’s Verona Pharma VRNA Stock Holding History

Endurance Wealth Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,000	Closed	-$20K	–	665
2022 Q3	$20K	Hold	2,000	–	–	﹤0.01%	407
2022 Q2	$8K	Hold	2,000	–	–	﹤0.01%	507
2022 Q1	$10K	Hold	2,000	–	–	﹤0.01%	516
2021 Q4	$13K	Buy	+2,000	New	+$10.2K	﹤0.01%	483
2021 Q3	–	Sell	-2,000	Closed	-$12K	–	652
2021 Q2	$12K	Hold	2,000	–	–	﹤0.01%	508
2021 Q1	$17K	Buy	+2,000	New	+$16.6K	﹤0.01%	475

Other funds holding VRNA

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return